Loading...
XSHG603108
Market cap1.21bUSD
Jan 09, Last price  
14.72CNY
1D
0.41%
1Q
-11.06%
Jan 2017
-13.31%
IPO
194.99%
Name

Shanghai Runda Medical Technology Co Ltd

Chart & Performance

D1W1MN
XSHG:603108 chart
P/E
32.51
P/S
0.97
EPS
0.45
Div Yield, %
4.25%
Shrs. gr., 5y
-0.02%
Rev. gr., 5y
8.93%
Revenues
9.15b
-12.84%
631,452,386772,338,8321,025,889,5261,358,503,3231,628,641,8682,164,688,8404,318,809,8415,964,339,2237,051,950,1827,069,156,2908,860,108,02710,494,418,6949,147,372,719
Net income
273m
-58.28%
54,495,55558,794,70767,940,01475,162,10491,760,316116,427,774219,186,704261,953,796511,101,489503,830,450598,200,717655,110,069273,296,495
CFO
802m
038,700,97231,623,69036,114,224000538,902,960246,678,613323,441,186371,112,6900801,750,549
Dividend
Jul 19, 20240.1 CNY/sh
Earnings
May 23, 2025

Profile

Shanghai Runda Medical Technology Co., Ltd. provides integrated medical laboratory services in China. It offers platform supply, laboratory design/renovation, laboratory standardization, and information management system services; medical solutions to help healthcare professionals in the areas of biochemistry, diabetes, POCT, immunoassay analyzer, and molecular biology diagnosis; professional technical services; and logistic services. The company was founded in 1999 and is based in Shanghai, China.
URL
http://www.rundamedical.com/
IPO date
May 27, 2015
Employees
Domiciled in
CN
Incorporated in
CN

Valuation

Title
CNY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFY
2023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
9,147,373
-12.84%
10,494,419
18.45%
Cost of revenue
8,282,485
8,847,280
Unusual Expense (Income)
NOPBT
864,888
1,647,138
NOPBT Margin
9.46%
15.70%
Operating Taxes
212,920
164,541
Tax Rate
24.62%
9.99%
NOPAT
651,969
1,482,597
Net income
273,296
-58.28%
655,110
9.51%
Dividends
(377,523)
(66,067)
Dividend yield
3.19%
1.10%
Proceeds from repurchase of equity
BB yield
Debt
Debt current
5,223,388
5,933,112
Long-term debt
1,342,525
1,038,261
Deferred revenue
17,794
17,919
Other long-term liabilities
74,249
34,759
Net debt
4,228,367
4,835,410
Cash flow
Cash from operating activities
801,751
CAPEX
(319,883)
Cash from investing activities
(295,792)
Cash from financing activities
(334,895)
488,133
FCF
668,605
(53,635)
Balance
Cash
1,126,061
1,113,552
Long term investments
1,211,484
1,022,410
Excess cash
1,880,177
1,611,241
Stockholders' equity
4,104,692
4,088,635
Invested Capital
10,073,379
10,172,304
ROIC
6.44%
16.02%
ROCE
7.20%
13.96%
EV
Common stock shares outstanding
581,482
596,781
Price
20.35
101.29%
10.11
-24.61%
Market cap
11,833,157
96.13%
6,033,452
-24.27%
EV
17,228,672
11,990,299
EBITDA
1,239,906
2,031,322
EV/EBITDA
13.90
5.90
Interest
334,043
317,923
Interest/NOPBT
38.62%
19.30%